series-c-plus
Stage
1
Investors
About
Rocket Pharmaceuticals develops gene therapies targeting rare inherited metabolic, neuromuscular, bone marrow-derived, and cardiovascular diseases, aiming to provide long-term curative treatments.
Explore Rocket Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.